Literature DB >> 12474181

Impact of quality scales on levels of evidence inferred from a systematic review of exercise therapy and low back pain.

Florence Colle1, François Rannou, Michel Revel, Jacques Fermanian, Serge Poiraudeau.   

Abstract

OBJECTIVE: To assess whether the scale used affects levels of evidence inferred from a systematic review of studies on exercise therapy and chronic low back pain (LBP).
DESIGN: Twenty trials previously analyzed in a systematic review were assessed by 2 readers using 16 different scales.
SETTING: Tertiary care teaching hospital in France. PARTICIPANTS: Chronic LBP patients.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: For the scales allowing classification into high- and low-quality trials, a rating system with 4 levels of evidence was used to summarize conclusions drawn. The Spearman rank correlation coefficient was used to assess correlations between the scores obtained with the different scales. Interrater reliability of the scales was assessed with the intraclass correlation coefficient and the Bland and Altman method, and the degree of agreement between the readers was calculated using the kappa coefficient.
RESULTS: Two of the 3 main results of the systematic review (conflicting evidence on the effectiveness of exercise therapy compared with inactive treatments; strong evidence that exercise therapy is more effective than usual care by a general practitioner) were influenced by the scale used. The range of the Spearman rank correlation coefficients between the different scales was wide (range,.49-.94), the interreader reliability of the scales was heterogeneous, and the interreader agreement was often low (kappa<or=.60 for 7/10 tests).
CONCLUSIONS: The use of summary scores to identify physical therapy trials of high quality is questionable. Different quality assessment scales should probably be used to assess pharmacologic interventions and physical therapies. Development and validation of quality scales specific to physical treatments are needed. Copyright 2002 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation

Entities:  

Mesh:

Year:  2002        PMID: 12474181     DOI: 10.1053/apmr.2002.35657

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  6 in total

Review 1.  Inconsistency in the items included in tools used in general health research and physical therapy to evaluate the methodological quality of randomized controlled trials: a descriptive analysis.

Authors:  Susan Armijo-Olivo; Jorge Fuentes; Maria Ospina; Humam Saltaji; Lisa Hartling
Journal:  BMC Med Res Methodol       Date:  2013-09-17       Impact factor: 4.615

2.  Management of a patient with lumbar segmental instability using a clinical predictor rule.

Authors:  Anna Ribaudo
Journal:  HSS J       Date:  2013-08-14

Review 3.  Failure of a numerical quality assessment scale to identify potential risk of bias in a systematic review: a comparison study.

Authors:  Seán R O'Connor; Mark A Tully; Brigid Ryan; Judy M Bradley; George D Baxter; Suzanne M McDonough
Journal:  BMC Res Notes       Date:  2015-06-06

4.  PEDro or Cochrane to Assess the Quality of Clinical Trials? A Meta-Epidemiological Study.

Authors:  Susan Armijo-Olivo; Bruno R da Costa; Greta G Cummings; Christine Ha; Jorge Fuentes; Humam Saltaji; Matthias Egger
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

5.  How should we evaluate the risk of bias of physical therapy trials?: a psychometric and meta-epidemiological approach towards developing guidelines for the design, conduct, and reporting of RCTs in Physical Therapy (PT) area: a study protocol.

Authors:  Susan Armijo-Olivo; Jorge Fuentes; Todd Rogers; Lisa Hartling; Humam Saltaji; Greta G Cummings
Journal:  Syst Rev       Date:  2013-09-26

Review 6.  The effectiveness of Pilates exercise in people with chronic low back pain: a systematic review.

Authors:  Cherie Wells; Gregory S Kolt; Paul Marshall; Bridget Hill; Andrea Bialocerkowski
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.